HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity

Journal of Autoimmunity

Volumn 31, Issue 4, 2008, Pages 339-344

  Akeno, Nagako ^a   Blackard, Jason T ^a   Tomer, Yaron ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Hepatitis C virus; Infection thyroid; Thyroiditis

Indexed keywords

CD81 ANTIGEN; INTERLEUKIN 8; MESSENGER RNA; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CYTOKINE PRODUCTION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC SUSCEPTIBILITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INFLAMMATION; LIVER CELL; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; THYROID CELL; THYROIDITIS;

ANTIGENS, CD; AUTOIMMUNITY; CELLS, CULTURED; HEPACIVIRUS; HUMANS; INTERLEUKIN-8; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; VIRAL ENVELOPE PROTEINS;

EID: 56549131461     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.08.001     Document Type: Article

References (47)

1. Tomer Y., and Davies T.F. Infection, thyroid disease and autoimmunity. Endocr Rev 14 (1993) 107-120
2. Tomer Y., and Davies T.F. Infections and autoimmune endocrine disease. Baillière's Clin Endocrinol Metab 9 (1995) 47-70
3. Mandac J.C., Chaudhry S., Sherman K.E., and Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43 4 (2006) 661-672
4. Tomer Y., and Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link?. Am J Med 117 1 (2004) 60-61
5. Tomer Y., Blackard J.T., and Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 36 4 (2007) 1051-1066
6. Tran A., Quaranta J.F., Benzaken S., Thiers V., Chau H.T., Hastier P., et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18 2 (1993) 253-257
7. Ganne-Carrie N., Medini A., Coderc E., Seror O., Christidis C., Grimbert S., et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 14 2 (2000) 189-193
8. Fernandez-Soto L., Gonzalez A., Escobar-Jimenez F., Vazquez R., Ocete E., Olea N., et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158 13 (1998) 1445-1448
9. Preziati D., La Rosa L., Covini G., Marcelli R., Rescalli S., Persani L., et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 132 5 (1995) 587-593
10. Antonelli A., Ferri C., Pampana A., Fallahi P., Nesti C., Pasquini M., et al. Thyroid disorders in chronic hepatitis C. Am J Med 117 1 (2004) 10-13
11. Obermayer-Straub P., and Manns M.P. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 16 3 (2001) 275-285
12. Toubi E., Gordon S., Kessel A., Rosner I., Rozenbaum M., Shoenfeld Y., et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 27 2 (2006) 134-139
13. Strassburg C.P., Vogel A., and Manns M.P. Autoimmunity and hepatitis C. Autoimmun Rev 2 6 (2003) 322-331
14. Blackard J.T., Kemmer N., and Sherman K.E. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44 1 (2006) 15-22
15. Laskus T., Radkowski M., Wang L.F., Vargas H., and Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 28 5 (1998) 1398-1401
16. Munshi N., Balasubramanian A., Koziel M., Ganju R.K., and Groopman J.E. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 188 8 (2003) 1192-1204
17. Balasubramanian A., Ganju R.K., and Groopman J.E. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis 194 5 (2006) 670-681
18. Balasubramanian A., Koziel M., Groopman J.E., and Ganju R.K. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Clin Infect Dis 41 Suppl 1 (2005) S32-S37
19. Balasubramanian A., Ganju R.K., and Groopman J.E. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 278 37 (2003) 35755-35766
20. Jacobson E.M., Huber A.K., Akeno N., Sivak M., Li C.W., Concepcion E., et al. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 8 (2007) 205-214
21. Knauf J.A., Elisei R., Mochly-Rosen D., Liron T., Chen X.N., Gonsky R., et al. Involvement of protein kinase C epsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. J Biol Chem 274 33 (1999) 23414-23425
22. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73 8 (1999) 6235-6244
23. Zhu L.X., Liu J., Xie Y.H., Kong Y.Y., Ye Y., Wang C.L., et al. Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells. World J Gastroenterol 10 20 (2004) 2972-2978
24. Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., and Alter M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 10 (2006) 705-714
25. Benoist C., and Mathis D. Autoimmunity. The pathogen connection. Nature 394 6690 (1998) 227-228
26. Fournie G.J., Mas M., Cautain B., Savignac M., Subra J.F., Pelletier L., et al. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 16 3 (2001) 319-326
27. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., and Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4 7 (1998) 781-785
28. Arata N., Ando T., Unger P., and Davies T.F. By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse. Clin Immunol 121 1 (2006) 108-117
29. Barth H., Liang T.J., and Baumert T.F. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44 3 (2006) 527-535
30. Fang X., Zeisel M.B., Wilpert J., Gissler B., Thimme R., Kreutz C., et al. Host cell responses induced by hepatitis C virus binding. Hepatology 43 6 (2006) 1326-1336
31. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195 1 (2002) 35-41
32. Wack A., Soldaini E., Tseng C., Nuti S., Klimpel G., and Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 31 1 (2001) 166-175
33. Rosa D., Saletti G., De Gregorio E., Zorat F., Comar C., D'Oro U., et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 102 (2005) 18544-18549
34. Landau D.A., Saadoun D., Calabrese L.H., and Cacoub P. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 6 8 (2007) 581-587
35. Ban Y., Greenberg D.A., Concepcion E., Skrabanek L., Villanueva R., and Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA 100 (2003) 15119-15124
36. Jacobson E.M., Concepcion E., Oashi T., and Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146 6 (2005) 2684-2691
37. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 11 (2000) 6606-6611
38. Vaidya B., Imrie H., Perros P., Young E.T., Kelly W.F., Carr D., et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8 7 (1999) 1195-1199
39. Ban Y., Davies T.F., Greenberg D.A., Kissin A., Marder B., Murphy B., et al. Analysis of the CTLA-4, CD28 and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4 (2003) 586-593
40. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 6939 (2003) 506-511
41. Velaga M.R., Wilson V., Jennings C.E., Owen C.J., Herington S., Donaldson P.T., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89 11 (2004) 5862-5865
42. Dechairo B.M., Zabaneh D., Collins J., Brand O., Dawson G.J., Green A.P., et al. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13 11 (2005) 1223-1230
43. Jacobson E.M., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 1-2 (2008) 58-62
44. Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Osman R., Oashi T., et al. Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease. Genes Immun 5 (2004) 203-208
45. Jacobson E.M., and Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28 (2007) 85-98
46. Ban Y., Tozaki T., Tobe T., Ban Y., Jacobson E.M., Concepcion E.S., et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts. J Autoimmun 28 (2007) 201-207
47. Oppenheim Y., Ban Y., and Tomer Y. Interferon induced autoimmune thyroid disease (AITD): a model for human autoimmunity. Autoimmun Rev 3 5 (2004) 388-393